SMTL ID : 2h8h.1

Src kinase in complex with a quinazoline inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x H8H: N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE(Non-covalent)

H8H.1: 18 residues within 4Å: Chain A: L.275, G.276, V.283, A.295, K.297, I.338, T.340, E.341, Y.342, M.343, S.344, K.345, G.346, S.347, A.392, N.393, L.395, D.406 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.275, A:K.297, A:Y.342, A:D.406 Hydrogen bonds: A:M.343

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hennequin, L.F. et al., N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J.Med.Chem. (2006)

Release Date

2006-11-21

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase Src